Literature DB >> 21559802

Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms.

Rebecca L Ashare1, Larry W Hawk.   

Abstract

RATIONALE: Impulsivity, a multifaceted construct that includes inhibitory control and heightened preference for immediate reward, is central to models of drug use and abuse. Within a self-medication framework, abstinence from smoking may lead to an increase in impulsive behavior and the likelihood of relapse, particularly among persons with disorders (e.g., attention-deficit/hyperactivity disorder, ADHD) and personality traits (e.g., impulsivity) linked to impulsive behavior.
OBJECTIVES: This study aimed to examine the effects of smoking abstinence on multiple measures of impulsivity among a non-clinical sample of adult smokers selected for high and low levels of ADHD symptoms.
METHODS: In a within-subjects design, participants selected for high or low levels of self-reported ADHD symptoms (N = 56) completed sessions following overnight abstinence and when smoking as usual (order counterbalanced). Measures of impulsive behavior included response inhibition (i.e., stop signal task), interference control (i.e., attentional modification of prepulse inhibition (PPI) of startle), and impulsive choice (i.e., hypothetical delay discounting).
RESULTS: As hypothesized, abstinence decreased response inhibition and PPI. Although ADHD symptoms moderated abstinence effects on impulsive choice and response inhibition, the pattern was opposite to our predictions: the low-ADHD group responded more impulsively when abstinent, whereas the high-ADHD group was relatively unaffected by abstinence.
CONCLUSIONS: These findings highlight the importance of utilizing multiple laboratory measures to examine a multifactorial construct such as impulsive behavior and raise questions about how best to assess symptoms of ADHD and impulsivity among non-abstinent smokers.

Entities:  

Mesh:

Year:  2011        PMID: 21559802      PMCID: PMC3184469          DOI: 10.1007/s00213-011-2324-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

Review 1.  Varieties of impulsivity.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

2.  Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder.

Authors:  Rebecca L Ashare; Larry W Hawk; Keri Shiels; Jessica D Rhodes; William E Pelham; James G Waxmonsky
Journal:  Psychophysiology       Date:  2010-03-10       Impact factor: 4.016

3.  A randomized, controlled trial of financial incentives for smoking cessation.

Authors:  Kevin G Volpp; Andrea B Troxel; Mark V Pauly; Henry A Glick; Andrea Puig; David A Asch; Robert Galvin; Jingsan Zhu; Fei Wan; Jill DeGuzman; Elizabeth Corbett; Janet Weiner; Janet Audrain-McGovern
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

4.  Early attentional deficits in an attention-to-prepulse paradigm in ADHD adults.

Authors:  Annette Conzelmann; Paul Pauli; Ronald F Mucha; Christian P Jacob; Antje B M Gerdes; Jasmin Romanos; Christina G Bähne; Monika Heine; Andrea Boreatti-Hümmer; Georg W Alpers; Andreas J Fallgatter; Andreas Warnke; Klaus-Peter Lesch; Peter Weyers
Journal:  J Abnorm Psychol       Date:  2010-08

5.  Measures of impulsivity in cigarette smokers and non-smokers.

Authors:  S H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

6.  Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers.

Authors:  Kevin M Gray; Nathaniel L Baker; Matthew J Carpenter; A Lee Lewis; Himanshu P Upadhyaya
Journal:  Am J Addict       Date:  2010 Jul-Aug

Review 7.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 8.  Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.

Authors:  Stephanie M Groman; Alex S James; J David Jentsch
Journal:  Neurosci Biobehav Rev       Date:  2008-08-22       Impact factor: 8.989

9.  Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder.

Authors:  Keri Shiels; Larry W Hawk; Brady Reynolds; Rebecca J Mazzullo; Jessica D Rhodes; William E Pelham; James G Waxmonsky; Brian P Gangloff
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

10.  Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function.

Authors:  Eldon T Mueller; Reid D Landes; Benjamin P Kowal; Richard Yi; Maxine L Stitzer; Cody A Burnett; Warren K Bickel
Journal:  Behav Pharmacol       Date:  2009-09       Impact factor: 2.293

View more
  37 in total

1.  Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Authors:  Rebecca L Ashare; Riju Ray; Caryn Lerman; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2012-05-15       Impact factor: 4.492

2.  The moderating role of cognitive capacities in the association between social norms and drinking behaviors.

Authors:  Samuel N Meisel; Craig R Colder; Larry W Hawk
Journal:  Alcohol Clin Exp Res       Date:  2015-05-22       Impact factor: 3.455

3.  Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice.

Authors:  K K Higa; A Grim; M E Kamenski; J van Enkhuizen; X Zhou; K Li; J C Naviaux; L Wang; R K Naviaux; M A Geyer; A Markou; J W Young
Journal:  Psychopharmacology (Berl)       Date:  2017-02-28       Impact factor: 4.530

4.  A cognitive model-based approach to testing mechanistic explanations for neuropsychological decrements during tobacco abstinence.

Authors:  Alexander Weigard; Cynthia Huang-Pollock; Andrew Heathcote; Larry Hawk; Nicolas J Schlienz
Journal:  Psychopharmacology (Berl)       Date:  2018-09-04       Impact factor: 4.530

Review 5.  The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.

Authors:  Warren K Bickel; Mikhail N Koffarnus; Lara Moody; A George Wilson
Journal:  Neuropharmacology       Date:  2013-06-24       Impact factor: 5.250

6.  Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.

Authors:  Rebecca L Ashare; Sherry A McKee
Journal:  Exp Clin Psychopharmacol       Date:  2011-09-26       Impact factor: 3.157

7.  Sex differences in the reduction of impulsive choice (delay discounting) for cocaine in rats with atomoxetine and progesterone.

Authors:  John R Smethells; Natashia L Swalve; Lynn E Eberly; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2016-06-20       Impact factor: 4.530

8.  Alternate versions of a fixed-choice, delay-discounting assessment for repeated-measures designs.

Authors:  Jinyi Kuang; Hannah Milhorn; Allison Stuppy-Sullivan; Soyeon Jung; Richard Yi
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

9.  The countermanding task revisited: fast stimulus detection is a key determinant of psychophysical performance.

Authors:  Emilio Salinas; Terrence R Stanford
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

10.  Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder.

Authors:  Scott R Vrana; Patrick S Calhoun; Michelle F Dennis; Angela C Kirby; Jean C Beckham
Journal:  J Psychopharmacol       Date:  2015-08-07       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.